The 1 February 2019 MBS files (XML, DOC, PDF and ZIP) can now be downloaded from the February 2019 downloads page.
The following changes will take effect from 1 February 2019:
EGFR Test for access to osimertinib for NSCLC patients
A test of tumour tissue from a patient with locally advanced or metastatic NSCLC to determine if the requirements relating to EGFR T790M gene status for access to osimertinib under othe PBS.
Remove specialist restriction from item 42505
'S' removed from item 42505